Preclinical Evaluation of a COVID-19 Vaccine Candidate Based on a Recombinant RBD Fusion Heterodimer of SARS-CoV-2.
Antonio Barreiro,Antoni Prenafeta,Gregori Bech-Sabat,Merce Roca, Eva Perozo Mur,Ricard March,Luis Gonzalez-Gonzalez,Laia Madrenas,Julia Corominas,Alex Fernandez,Alexandra Moros,Manuel Canete,Merce Molas, Thais Pentinat-Pelegrin, Clara Panosa, Alberto Moreno, Ester Puigvert Molas, Eva Pol Vilarrassa, Jordi Palmada,Carme Garriga, Teresa Prat Cabanas,Javier Iglesias-Fernandez,Julia Vergara-Alert,Cristina Lorca-Oro,Nuria Roca,Leira Fernandez-Bastit,Jordi Rodon,Monica Perez,Joaquim Segales,Edwards Pradenas,Silvia Marfil,Benjamin Trinite,Raquel Ortiz,Bonaventura Clotet,Julia Blanco, Jorge Diaz Pedroza, Rosa Ampudia Carrasco, Yaiza Rosales Salgado, Jordina Loubat-Casanovas,Sara Capdevila Larripa, Julia Garcia Prado,Jordi Barretina,Marta Sistere-Oro,Paula Cebollada Rica,Andreas Meyerhans,Laura Ferrer ISCIENCE（2023）
Key words
Health sciences,Immune response,Immunology,Microbiology
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper